Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3355558rdf:typepubmed:Citationlld:pubmed
pubmed-article:3355558lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0019046lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0038734lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0030011lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C1527240lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0020923lld:lifeskim
pubmed-article:3355558lifeskim:mentionsumls-concept:C0061344lld:lifeskim
pubmed-article:3355558pubmed:issue3lld:pubmed
pubmed-article:3355558pubmed:dateCreated1988-5-11lld:pubmed
pubmed-article:3355558pubmed:abstractTextThe binding to hemoglobin of synthetic 2-hydroxyamino-6-methyldipyrido[1,2-a: 3',2'-d] imidazole from the carcinogenic product of L-glutamic acid pyrolysis 2-amino-6-methyldipyrido[1,2-a: 3',2'-d] imidazole were investigated in vitro. The hydroxylamine required oxidation to its nitroso derivative to bind to rat hemoglobin through thiol groups. Oxidation of the hydroxylamine to the nitroso form was found to be enhanced by oxyhemoglobin and superoxide dismutase at pH 7.4 under aerobic conditions. Since these conditions might also enhance this oxidation in vivo, the conversion of the DNA-reactive arylhydroxylamines to the DNA-non-reactive nitroso compounds and their subsequent binding to highly abundant thiol groups of proteins could be considered as a process for detoxification of toxic arylhydroxylamines.lld:pubmed
pubmed-article:3355558pubmed:languageenglld:pubmed
pubmed-article:3355558pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:citationSubsetIMlld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3355558pubmed:statusMEDLINElld:pubmed
pubmed-article:3355558pubmed:monthMarlld:pubmed
pubmed-article:3355558pubmed:issn0006-291Xlld:pubmed
pubmed-article:3355558pubmed:authorpubmed-author:SugimuraTTlld:pubmed
pubmed-article:3355558pubmed:authorpubmed-author:TsudaMMlld:pubmed
pubmed-article:3355558pubmed:authorpubmed-author:MondenYYlld:pubmed
pubmed-article:3355558pubmed:authorpubmed-author:UmemotoAAlld:pubmed
pubmed-article:3355558pubmed:authorpubmed-author:GrivasSSlld:pubmed
pubmed-article:3355558pubmed:issnTypePrintlld:pubmed
pubmed-article:3355558pubmed:day30lld:pubmed
pubmed-article:3355558pubmed:volume151lld:pubmed
pubmed-article:3355558pubmed:ownerNLMlld:pubmed
pubmed-article:3355558pubmed:authorsCompleteYlld:pubmed
pubmed-article:3355558pubmed:pagination1326-31lld:pubmed
pubmed-article:3355558pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:meshHeadingpubmed-meshheading:3355558-...lld:pubmed
pubmed-article:3355558pubmed:year1988lld:pubmed
pubmed-article:3355558pubmed:articleTitleOxidation of the 2-hydroxyamino derivative of 2-amino-6-methyl-dipyrido[1,2-a: 3',2'-d] imidazole (Glu-P-1) to its 2-nitroso form, an ultimate form reacting with hemoglobin thiol groups.lld:pubmed
pubmed-article:3355558pubmed:affiliationBiochemistry Division, National Cancer Center Research Institute, Tokyo, Japan.lld:pubmed
pubmed-article:3355558pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3355558pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3355558lld:pubmed